ArticleParasitology research2025
Medication adherence and treatment outcomes in intestinal parasitic infections in rural Egypt: a cross-sectional follow-up study.
Article in Parasitology research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intestinal parasitic infections (IPIs) remain a pressing global health issue, particularly in low-resource settings where inadequate sanitation, poor hygiene, and limited healthcare access contribute to persistent transmission. In rural Egypt, IPIs are endemic and impose substantial health and economic burdens. This study aimed to assess medication adherence patterns among patients diagnosed with IPIs, identify barriers to adherence, and evaluate associated treatment outcomes in some rural health units in northern Egypt. A cross-sectional and follow-up study was conducted among 450 patients with laboratory-confirmed IPIs across seven rural health units. Data were collected through medical record reviews, structured questionnaires, and the Morisky 8-Item Medication Adherence Scale. Adherence barriers and treatment outcomes were analyzed using descriptive and inferential statistics. Participants had a wide age range (mean age 20.7 ± 17.4 years), with 86% residing in rural areas. Adherence levels were varied: 41.6% high, 18.4% moderate, and 40% low. Key barriers included side effects, forgetfulness, and disrupted routines. Clinical improvement is observed in 82% of patients during the first follow-up and in all patients who completed the third follow-up visit. However, high attrition during follow-up limited confirmation of long-term outcomes, with only 19.8% completing all visits. Notably, patients with higher adherence scores paradoxically showed lower improvement rates (p = 0.048), suggesting complex adherence-outcome dynamics that might be confounded by reinfection or measurement limitations. While antiparasitic treatments were generally effective, adherence varied widely and was influenced by socioeconomic and behavioral factors. In conclusion, reinfection and follow-up attrition remain major challenges. Public health interventions must prioritize patient education, improved follow-up systems, and targeted strategies to enhance adherence and reduce reinfection in high-risk communities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.